TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/07/2025
Back to search
Official data from USPTO
ATHENIUM PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ATHENIUM PHARMACEUTICALS
ST13
US500000076188883Class
42
Filing
76188883
Registration
2759532
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
02/11/2025
Trademark type
Word
Nice classes
42
Filing date
01/03/2001
Registration date
09/02/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/14/2024
Last transaction
02/11/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/18/2002
First use in commerce
03/18/2002
Drawing code
1
Owner type
02
Owner location
Nashville, TN, US
Examiner
ZAK, HENRY
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Danco Investors Group, L.P.
Representatives
Robert L. Brewer BASS BERRY & SIMS PLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical servicesdrug testing and research and development
Publications
History of USPTO decisions and trademark events.
44 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/07/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/14/2024
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/14/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/14/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/05/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
02/24/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/24/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/31/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/19/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/19/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/19/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/19/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/19/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/19/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/19/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/19/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/19/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/10/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/04/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
08/30/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
08/30/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/14/2009
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/12/2009
PLGL
ASSIGNED TO PARALEGAL
09/10/2009
E815
TEAS SECTION 8 & 15 RECEIVED
09/02/2009
CFIT
CASE FILE IN TICRS
07/06/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/27/2003
EEXT
SOU TEAS EXTENSION RECEIVED
06/16/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/17/2002
IUAF
USE AMENDMENT FILED
12/17/2002
EX1G
SOU EXTENSION 1 GRANTED
12/17/2002
EXT1
SOU EXTENSION 1 FILED
12/17/2002
PAPER RECEIVED
12/17/2002
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/18/2002
PUBO
PUBLISHED FOR OPPOSITION
03/26/2002
NPUB
NOTICE OF PUBLICATION
03/06/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/10/2001
CNRT
NON-FINAL ACTION MAILED
05/25/2001
DOCK
ASSIGNED TO EXAMINER
05/24/2001
Continuous trademark protection
Get notified about every new filing that threatens ATHENIUM PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.